Key result
T1 mapping with cardiac magnetic resonance provides a quantitative method to evaluate myocardial extracellular volume fraction and characterize diffuse myocardial diseases such as fibrosis.
T1 mapping is a promising CMR technique for quantitative evaluation of myocardial tissue, overcoming limitations of traditional late gadolinium enhancement in detecting diffuse myocardial disease.
May support T1 mapping for diffuse fibrosis assessment in CMR; leaves open prospective outcome validation before routine use.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2013) conducted a review in Myocardial disease. T1 mapping (Cardiac Magnetic Resonance) was evaluated. T1 mapping with cardiac magnetic resonance provides a quantitative method to evaluate myocardial extracellular volume fraction and characterize diffuse myocardial diseases such as fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: